Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 24, 1999

View Archived Issues

SR Pharma Enters Deal With Sakai, Completes

Rearranged Telomeres May Be A Link To Mental Retardation

Irish Biotechnology Sector Facing Famine In Financing

EC Seeks Broader Support For Positions At World Trade Talks

genOway Seeks To Accelerate Genetics-Based Development

XTL Partners With Roche To Test Hepatitis C Drug

Cyclacel Recipient Of Fund To Boost Scottish Biotech

Canadian Scientists Find A Trigger For Bone Destruction

Other News To Note

Scotia Gains Orphan Status For Photodynamic Therapy

IDM Opens New Laboratory On Site Of Paris University

Oxford Glycosciences Finds Differences In Two Cell Types

Otogene Getting Funding To Develop Hearing Loss Drugs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...